AWHL Aspira Women's Health Inc.

Overview and Growth

Fiscal 2025 results for Aspira Women's Health Inc. combined $343.00K of revenue with net loss of $12.78M and an operating cash outflow of $7.03M. At $343.00K, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Revenue was 96.3% below fiscal 2024 revenue of $9.18M, marking a top-line contraction. On a per-share basis, diluted EPS was -$0.37, which connects the reported earnings outcome with the company’s diluted share count. The diluted weighted-average share count was 34.10M, linking total earnings with the per-share result received by shareholders. Compared with 14.13M diluted shares in fiscal 2024, the current 34.10M base was 141.3% higher. The company employed $5.46M of total assets, the balance-sheet base supporting its current operating and cash-flow results. The revenue-to-assets relationship was 0.06x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

Gross profit was $5.92M, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. The reported operating result was an operating loss of $7.91M, reflecting costs that exceeded gross profit. The bottom-line result was a net loss of $12.78M after operating, financing, tax, and other recognized items. The company reported negative EBITDA of $7.88M, adding a pre-interest, tax, depreciation, and amortization view of the operating shortfall. The company reported a pretax loss of $12.78M, before the effect of income taxes. The loss-to-assets relationship was 234.2%, placing the bottom-line deficit against the company’s resource base. The net loss narrowed to $12.78M from $13.09M in fiscal 2024.

Liquidity and Capital Structure

At period end, the $5.46M asset base was financed through $12.39M of liabilities and -$6.93M of equity. Equity was negative at -$6.93M, meaning liabilities exceeded the residual book value available to shareholders and weakening balance-sheet resilience. The near-term balance sheet paired $4.06M of current assets with $3.46M of current liabilities at the reporting date. Current assets covered current liabilities by 1.17x, leaving a positive buffer for near-term obligations. Reported cash and equivalents were $1.75M, separating immediately recognizable cash resources from the rest of the current-asset base. Cash and equivalents represented 50.6% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. The company carried $1.28M of total debt at period end, which frames its leverage and debt-service burden. Debt represented 23.4% of total assets, placing borrowing in the context of the company’s full resource base. Equity equaled -127.1% of assets, showing the shareholder-capital layer within the company’s balance sheet. Relative to total assets, liabilities measured 227.1%, complementing the separate equity-based view of the company’s capital structure. Cash and equivalents equaled 32.2% of total assets, showing the liquid cash component within the company’s broader resource base. Total assets were 0.6% lower than fiscal 2024 assets of $5.49M, measuring the company’s own balance-sheet change. Compared with $1.77M in fiscal 2024, the current cash balance moved 0.8% and finished lower.

Cash Flow and Earnings Quality

The company reported an operating cash outflow of $7.03M, rather than cash generation from operations. The company spent $16.00K on capital expenditures while operations also absorbed cash, so both ongoing activity and investment drew on liquidity during the period. Operating cash flow and capital spending combined to leave a $7.04M cash deficit after capital spending. The free-cash-flow deficit equaled 129.1% of total assets, placing the cash shortfall against the company’s resource base. The operating cash outflow narrowed to $7.03M from $12.11M in fiscal 2024.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 21, 2026.